◆ NeutralBBNX
Robbins LLP Reminds BBNX Stockholders of its Investigation into Beta Bionics, Inc.; Contact the Firm for Information
GlobeNewswire Inc.·
Shareholder rights law firm Robbins LLP is investigating Beta Bionics, Inc. (NASDAQ: BBNX) for potential securities law violations and breach of fiduciary duties. The investigation follows the company's January 8, 2026 announcement of fourth quarter 2025 results showing new patient starts of at least 5,581 (36% year-over-year growth), which fell short of analyst expectations and represented a significant slowdown from the prior quarter's 68% growth. The stock declined more than 35% following the announcement.
Read Full Article at GlobeNewswire Inc. →